Ken Griffin’s Revolution Medicines RVMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$269M Buy
1,310,983
+721,077
+122% +$143M 0.03% 455
2026
Q2
$110M Buy
589,906
+189,853
+47% +$27.7M 0.01% 906
2026
Q1
$38.9M Sell
400,053
-902,308
-69% -$91.1M 0.01% 1594
2025
Q4
$104M Buy
1,302,361
+122,276
+10% +$8.02M 0.02% 843
2025
Q3
$55.1M Sell
1,180,085
-297,590
-20% -$11.7M 0.01% 1283
2025
Q2
$54.4M Buy
1,477,675
+1,344,608
+1,010% +$51.7M 0.01% 1180
2025
Q1
$4.71M Sell
133,067
-3,997
-3% -$162K ﹤0.01% 3973
2024
Q4
$6M Sell
137,064
-143,873
-51% -$7.26M ﹤0.01% 3675
2024
Q3
$12.7M Sell
280,937
-127,905
-31% -$5.57M ﹤0.01% 2569
2024
Q2
$15.9M Sell
408,842
-179,246
-30% -$6.7M ﹤0.01% 2246
2024
Q1
$19M Sell
588,088
-315,941
-35% -$9.36M ﹤0.01% 2123
2023
Q4
$25.9M Buy
904,029
+657,571
+267% +$15.8M 0.01% 1766
2023
Q3
$6.82M Buy
+246,458
New +$7.31M ﹤0.01% 3198
2023
Q2
– Sell
-323
Closed -$7.92K – 15103
2023
Q1
$7K Sell
323
-176,416
-100% -$4.34M ﹤0.01% 13767
2022
Q4
$4.21M Buy
176,739
+152,687
+635% +$3.25M ﹤0.01% 4150
2022
Q3
$474K Sell
24,052
-173,008
-88% -$3.8M ﹤0.01% 8572
2022
Q2
$3.84M Buy
197,060
+130,258
+195% +$2.54M ﹤0.01% 4295
2022
Q1
$1.7M Sell
66,802
-297,103
-82% -$6.47M ﹤0.01% 6448
2021
Q4
$9.16M Buy
363,905
+270,483
+290% +$7.62M ﹤0.01% 3223
2021
Q3
$2.57M Sell
93,422
-104,339
-53% -$3.04M ﹤0.01% 5741
2021
Q2
$6.28M Sell
197,761
-919,431
-82% -$32.1M ﹤0.01% 3955
2021
Q1
$51.3M Sell
1,117,192
-122,484
-10% -$5.49M 0.01% 1019
2020
Q4
$49.1M Buy
1,239,676
+865,211
+231% +$34.2M 0.01% 956
2020
Q3
$13M Sell
374,465
-47,471
-11% -$1.31M ﹤0.01% 1990
2020
Q2
$13.3M Buy
421,936
+73,294
+21% +$2.3M ﹤0.01% 1896
2020
Q1
$7.64M Buy
+348,642
New +$9.7M ﹤0.01% 2182

Other funds holding RVMD

Ken Griffin's RVMD Position: Q3 2026 in Review

Ken Griffin increased its Revolution Medicines (RVMD) stake by 122% in Q3 2026, buying an estimated $143M and bringing the position to 1,310,983 shares worth $269M. The position accounts for 0.03% of the portfolio, ranked #455.

Ken Griffin first reported a position in RVMD in Q1 2020 and has held it in 26 quarters since. 759 funds tracked by Wall St. Rank hold RVMD as of Q3 2026.

  • Ken Griffin held 1,310,983 shares of Revolution Medicines worth $269M as of Q3 2026.
  • Ken Griffin bought 721,077 Revolution Medicines shares in Q3 2026, an estimated $143M.
  • Revolution Medicines made up 0.03% of Ken Griffin's portfolio in Q3 2026, its #455 holding.
  • Ken Griffin first reported a position in Revolution Medicines in Q1 2020 and has held it in 26 quarters since.
  • 759 funds tracked by Wall St. Rank held Revolution Medicines as of Q3 2026.

Based on Citadel Advisors's 13F filing for Q3 2026, filed 16 Nov 2026.